Parmenion launches new portfolio range
Parmenion has launched range portfolios covering ten target income levels and risk grades
Parmenion has launched range portfolios covering ten target income levels and risk grades
|
|
Old Mutuals Richard Buxton asks, if the current size and sector rotation in the UK stock market is temporary, or the start of something more worrisome?
|
|
The wealth manager saw a 215% jump in pre-tax profits as redundancy costs fell and discretionary AUM rose.
|
|
River and Mercantile and Lloyds TSB deals may be key to asset manager and bank floats in 2014
|
|
Fundsmith is seeking to raise between £100m and £250m in order to launch its new Emerging Equities investment trust.
|
|
European equities are no longer obviously inexpensive, argues William Hobbs, but, an attractive dividend yield, a still expected earnings rebound and unevenly dissipating risks could reward investors.
|
|
Pfizers attempt to coax AstraZeneca’s major shareholders into forcing its board to negotiate on a potential takeover ultimately come to nothing
|
|
Fidelity Worldwide Investments has cut the costs of its equity range of index products in an effort to become the dominant player in the space.
|
|
With investors on the lookout for any signs that valuations wont be backed by earnings corporates cannot be seen to be underperforming.
|
|
Blackrock has publicly urged the AstraZeneca board to re-engage with potential buyer Pfizer
|
|
Results of European elections under way today are very unlikely to cause major disruption in markets, fund managers have said
|
|
Periodic mini-crises have forced central banks to take aggressive action to shore up their currencies, often at the expense of the outlook for domestic growth, writes Threadneedle’s Mark Burgess.
|
|